EW

#252
Edwards Lifesciences Corp
86.52
+1.87%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
86.07
86.84
Intervallo Annuale
65.94
87.89
Variazione giornaliera
+1.87%
Variazione Mensile
+3.80%
Variazione di 6 mesi
+7.25%
Variazione Annuale
+20.79%
Chiusura Precedente
84.93
Open
86.13
Bid
Ask
Low
86.07
High
86.84
Volume
1 865
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization 50.6 B
  • Employee 16 K
  • Founded N/A
  • CEO N/A
  • Website www.edwards.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRXP69
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
46.58
Price to sales ratio
8.2
Dividends per share
—
Dividend yield %
—

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland.

Notizie